在6至17岁具有功能性便秘的儿童中对林纳克洛的随机对照试验
Carlo Di Lorenzo1, Samuel Nurko2, Jeffrey S Hyams3
1Nationwide Children's Hospital, Columbus, Ohio, USA.
利纳克洛提德在功能性便秘的儿童中显示出改善肠道排便的趋势. 这种药物耐受性很好,腹是最常见的副作用.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 功能性便秘 (FC) 是儿童常见的胃肠道疾病.
- 利纳克洛提德是一种瓜尼酸环酶-C激动剂,已被批准用于治疗儿科患者的FC.
- 评估儿童FC治疗的最佳剂量至关重要.
研究的目的:
- 评估各种林纳克洛提德剂量的安全性和有效性,用于患有功能性便秘的6至17岁儿童.
- 为了确定儿科FC中利纳克洛提德的剂量反应关系.
主要方法:
- 一个多中心,随机,双盲,安慰剂控制的第二阶段研究.
- 173名患有FC的儿童被随机分配给每天接受利纳克洛或安慰剂.
- 在4周内,通过每周自发排便 (SBM) 频率的变化来衡量有效性.
主要成果:
- 随着利纳克洛提德剂量增加,观察到平均SBM频率的数值改善.
- 较高剂量在两个年龄组 (6-11岁和12-17岁) 显示出更大的疗效趋势.
- 腹是最常见的不良事件,通常是轻微的,不是严重的.
结论:
- 在研究的儿科患者群体中,利纳克洛提德表现出了有利的安全性.
- 随着更高的林纳克洛提德剂量,人们注意到效率改善的趋势.
- 需要进一步的研究来确认疗效和优化剂量.
更多相关视频
08:24Author Spotlight: Exploring the Potential of Massage Therapy in Cerebral Palsy Using Animal Models
Published on: August 11, 2023
03:50Acupoint Application Combined with Acupoint Massage for Treating Constipation in a Patient with Chronic Obstructive Pulmonary Disease
Published on: August 18, 2023
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs Affecting GI Tract Motility: Other Laxatives
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
